Bayer Logo Bayer Logo Bayer Logo Bayer Logo

A TREATMENT
FOR PAH
AND CTEPH

The first and only soluble guanylate cyclase
(sGC) stimulator approved by the FDA.1

Bayer Logo Bayer Logo Bayer Logo Bayer Logo

A TREATMENT
FOR PAH AND CTEPH

The first and only soluble guanylate cyclase
(sGC) stimulator approved by the FDA.1

PRESCRIBED TO MORE THAN 15,000 PATIENTS2*

The first and only approved sGC stimulator, Adempas is the only treatment for adults with PAH (WHO Group 1) and inoperable or persistent/recurrent CTEPH (WHO Group 4) after surgery.1†

*Prescriptions written do not equate to prescriptions fulfilled.
Studies establishing effectiveness included predominantly patients with WHO functional class II-III.1

CTEPH=chronic thromboembolic pulmonary hypertension; PAH=pulmonary arterial hypertension; WHO=World Health Organization

ADEMPAS IS THE FIRST AND ONLY sGC STIMULATOR APPROVED BY THE FDA FOR TREATING 2 TYPES OF PULMONARY HYPERTENSION (PH) IN ADULTS1

CONSIDER ADEMPAS AS PART OF YOUR
TREATMENT ALGORITHM FOR THE FOLLOWING PATIENT TYPES1:

CONSIDER ADEMPAS AS PART OF YOUR TREATMENT ALGORITHM FOR THE FOLLOWING PATIENT TYPES1:

Lungs
PAH (WHO GROUP 1)
  • PAH treatment-naïve
  • PAH with ERA therapy
  • PAH with PCA therapy
Lungs
CTEPH (WHO GROUP 4)
  • CTEPH inoperable
  • CTEPH recurrent/persistent after surgery

Studies establishing effectiveness included predominantly patients with WHO functional class II-III.1

Review the patient profiles for PAH and CTEPH.

ERA=endothelin receptor antagonist; PCA=prostacyclin analog

Ask Question

Want to learn how Adempas works?

Watch the MOA video here.

Ask Question

Want to learn how Adempas works?

Watch the MOA video here.

 
MORE IMPORTANT SAFETY INFORMATION LESS IMPORTANT SAFETY INFORMATION
References:
  1. Adempas Prescribing Information. Whippany, NJ. Bayer Pharmaceuticals Inc., 2018.

  2. Daily Metric Report. Data on file. United Biosource Corporation. Accessed March 07, 2019.